Evelyn Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Evelyn Partners's VRTX Position: Q3 2026 in Review
Evelyn Partners held its Vertex Pharmaceuticals (VRTX) position steady in Q3 2026 at 47 shares worth $24.6K. The position accounts for ﹤0.01% of the portfolio, ranked #497.
Evelyn Partners first reported a position in VRTX in Q2 2026 and has held it in 2 quarters since. 1,772 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.
- Evelyn Partners held 47 shares of Vertex Pharmaceuticals worth $24.6K as of Q3 2026.
- Evelyn Partners left its Vertex Pharmaceuticals share count unchanged in Q3 2026.
- Vertex Pharmaceuticals made up ﹤0.01% of Evelyn Partners's portfolio in Q3 2026, its #497 holding.
- Evelyn Partners first reported a position in Vertex Pharmaceuticals in Q2 2026 and has held it in 2 quarters since.
- 1,772 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.
Based on Evelyn Partners's 13F filing for Q3 2026, filed 10 Nov 2026.